SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001047469-16-010396
Filing Date
2016-02-25
Accepted
2016-02-25 08:20:48
Documents
83
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a2227476z10-ka.htm 10-K/A 1600961
2 EX-10.4 a2226904zex-10_4.htm EX-10.4 111983
3 EX-10.12 a2226904zex-10_12.htm EX-10.12 52464
4 EX-21.1 a2226904zex-21_1.htm EX-21.1 4336
5 EX-23.1 a2226904zex-23_1.htm EX-23.1 2858
6 EX-31.1 a2226904zex-31_1.htm EX-31.1 8867
7 EX-31.2 a2226904zex-31_2.htm EX-31.2 8874
8 EX-32 a2226904zex-32.htm EX-32 7433
15 G234232MM03I001.JPG g234232mm03i001.jpg GRAPHIC 74216
16 G861164.JPG g861164.jpg GRAPHIC 37769
17 G234232MM03I002.JPG g234232mm03i002.jpg GRAPHIC 90047
18 G234232KY03I001.GIF g234232ky03i001.gif GRAPHIC 111012
  Complete submission text file 0001047469-16-010396.txt   9153134

Data Files

Seq Description Document Type Size
9 EX-101.INS cldx-20151231.xml EX-101.INS 2273694
10 EX-101.SCH cldx-20151231.xsd EX-101.SCH 59571
11 EX-101.CAL cldx-20151231_cal.xml EX-101.CAL 76454
12 EX-101.LAB cldx-20151231_lab.xml EX-101.LAB 595779
13 EX-101.PRE cldx-20151231_pre.xml EX-101.PRE 391503
14 EX-101.DEF cldx-20151231_def.xml EX-101.DEF 192281
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-15006 | Film No.: 161453941
SIC: 2835 In Vitro & In Vivo Diagnostic Substances